Hikma Pharmaceuticals (HKMPY)
OTC: HKMPY
· Real-Time Price · USD
48.52
-0.24 (-0.49%)
At close: Oct 15, 2025, 3:59 PM
48.73
0.44%
Pre-market: Oct 15, 2025, 11:12 AM EDT
Hikma Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 3.13B | 2.88B | 2.52B | 2.55B |
Cost of Revenue | 1.71B | 1.47B | 1.28B | 1.25B |
Gross Profit | 1.42B | 1.41B | 1.24B | 1.3B |
Operating Income | 612M | 367M | 282M | 582M |
Interest Income | 8M | 7M | 3M | 30M |
Pretax Income | 455M | 281M | 233M | 544M |
Net Income | 359M | 190M | 188M | 421M |
Selling & General & Admin | 568M | 638M | 509M | 488M |
Research & Development | 141M | 149M | 144M | 143M |
Other Expenses | 94M | 253M | 303M | 88M |
Operating Expenses | 803M | 1.04B | 956M | 719M |
Interest Expense | 88M | 87M | 70M | 69M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.52B | 2.51B | 2.23B | 1.97B |
Income Tax Expense | 93M | 89M | 42M | 124M |
Shares Outstanding (Basic) | 110.67M | 111.18M | 111.86M | 115.5M |
Shares Outstanding (Diluted) | 111.75M | 111.18M | 112.5M | 116.5M |
EPS (Basic) | 3.24 | 1.70 | 1.68 | 3.64 |
EPS (Diluted) | 3.22 | 1.72 | 1.68 | 3.62 |
EBITDA | 727M | 559M | 493M | 766M |
EBIT | 530M | 368M | 498M | 599M |
Depreciation & Amortization | 197M | 191M | 190M | 167M |
Source: Financial Modeling Prep. Financial Sources.